Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

What Is A Drug Shortage? First EU Definition Due This Month

Executive Summary

Efforts to harmonize the notification and communication requirements for drug shortages in the EU will take a step forward this month when regulators adopt a common definition of a shortage together with a number of guidance documents. The situation with regard to drug shortages has been called a public health emergency.

You may also be interested in...



Defining & Reporting Drug Shortages in the EU - New Guidance

The EMA has produced two guidance documents on how sponsors should identify, notify and address medicines shortages, and how regulatory authorities should communicate information on shortages to the public and health care professionals.

EU Regulators Asked To Define 'Drug Shortages' Before Finalizing Notification Framework

The EU pharmaceutical industry has highlighted key aspects that it wants regulators to address when it comes to defining the term "drug shortages."

Three Major Regulators Launch Pilot To Reduce Duplication Of GMP Inspections

Regulatory bodies from Australia, Canada and the UK say a new pilot program will reduce the need for multiple inspections of the same site, while an MoU signed by Australia and Canada will cut the amount of documentary evidence required from drug sponsors seeking GMP clearances. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS125422

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel